RAGE: the beneficial and deleterious effects by diverse mechanisms of actions
- PMID: 21347704
- PMCID: PMC3932687
- DOI: 10.1007/s10059-011-0030-x
RAGE: the beneficial and deleterious effects by diverse mechanisms of actions
Abstract
Receptor for advanced glycation endproducts (RAGE) is a transmembrane protein that belongs to the immunoglobulin superfamily. RAGE is expressed ubiquitously-high in lung and moderate to low in a wide range of cells-in a tightly regulated manner at various stages of development. RAGE is a pattern recognition receptor that binds to multiple ligands, including amphoterin, members of the S100/calgranulin family, the integrin Mac-1, and amyloid β-peptide (Aβ). RAGE-ligand engagement effects the activation of diverse cascades that initiate and stimulate chronic stress pathways and repair, depending on the ligand, environment, and developmental stage. Further, RAGE-ligand interaction and the consequent upregulation of RAGE through a positive feedback loop are often associated with various diseases, including vascular disease, diabetes, cancer, and neurodegenerative disease. It is unknown how RAGE mediates these events, but such phenomena appear to be linked to the inflammatory response. In this review, we summarize the findings on RAGE from published reports and ongoing studies. Also, the implication of RAGE in Alzheimer disease, the most common neurodegenerative disease in the elderly population, will be discussed, with a focus on Aβ-RAGE interactions with regard to signaling pathways and their impact on cellular activity.
Figures



Similar articles
-
Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):249-66. doi: 10.2174/1568007054038210. Curr Drug Targets CNS Neurol Disord. 2005. PMID: 15975028 Review.
-
Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease.Rev Neurosci. 2009;20(2):95-110. doi: 10.1515/revneuro.2009.20.2.95. Rev Neurosci. 2009. PMID: 19774788 Review.
-
RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease.Front Biosci (Schol Ed). 2012 Jan 1;4(1):240-50. doi: 10.2741/s265. Front Biosci (Schol Ed). 2012. PMID: 22202057 Free PMC article. Review.
-
RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease.Curr Mol Med. 2007 Dec;7(8):735-42. doi: 10.2174/156652407783220741. Curr Mol Med. 2007. PMID: 18331231 Review.
-
Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.Ageing Res Rev. 2002 Feb;1(1):1-15. doi: 10.1016/s0047-6374(01)00366-9. Ageing Res Rev. 2002. PMID: 12039445 Review.
Cited by
-
Standardization and quality control in quantifying non-enzymatic oxidative protein modifications in relation to ageing and disease: Why is it important and why is it hard?Redox Biol. 2015 Aug;5:91-100. doi: 10.1016/j.redox.2015.04.001. Epub 2015 Apr 14. Redox Biol. 2015. PMID: 25909343 Free PMC article. Review.
-
Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer's Disease Development.Molecules. 2021 May 13;26(10):2897. doi: 10.3390/molecules26102897. Molecules. 2021. PMID: 34068293 Free PMC article. Review.
-
Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors.Int J Mol Sci. 2021 Jun 27;22(13):6904. doi: 10.3390/ijms22136904. Int J Mol Sci. 2021. PMID: 34199060 Free PMC article. Review.
-
Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death.PLoS One. 2012;7(4):e34929. doi: 10.1371/journal.pone.0034929. Epub 2012 Apr 13. PLoS One. 2012. PMID: 22514691 Free PMC article.
-
AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.Mol Cell Biochem. 2019 Sep;459(1-2):95-112. doi: 10.1007/s11010-019-03553-4. Epub 2019 May 11. Mol Cell Biochem. 2019. PMID: 31079281 Review.
References
-
- Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. (1997);336:1066–1071. - PubMed
-
- Basta G., Lazzerini G., Massaro M., Simoncini T., Tanganelli P., Fu C., Kislinger T., Stern D.M., Schmidt A.M., De Cate-rina R. Advanced glycation end products activate endo-thelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation. (2002);105:816–822. - PubMed
-
- Bianchi R., Adami C., Giambanco I., Donato R. S100B binding to RAGE in microglia stimulates COX-2 expression. J. Leukoc. Biol. (2007);81:108–118. - PubMed
-
- Bianchi R., Giambanco I., Donato R. S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha. Neurobiol. Aging. (2010);31:665–677. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials